Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-18 Purchase |
2021-11-19 1:21 pm |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
15,700 | $12.74 | $200,018 | 15,700 (Indirect) |
View |
| 2021-11-16 Purchase |
2021-11-18 5:00 pm |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
7,500 | $28.08 | $210,600 | 7,500 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-19 7:21 pm |
FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO |
68,971 | $38 | $2,620,898 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 08:57 am |
N/A 2035-03-31 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
36,979 | $0.98 | 36,979 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2024-03-26 Option Award |
2024-03-28 4:32 pm |
N/A 2034-03-26 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
44,024 | $3.83 | 44,024 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:22 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:41 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
139,355 | $0 | 221,886 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:30 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
66,831 | $0 | 82,531 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
42,191 | $0 | 42,191 (Direct) |
View |
Ownership |
2021-10-07 9:00 pm |
N/A 2031-08-18 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
0 | $0 | 15,725 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-09 5:06 pm |
N/A 2031-09-07 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-09 Tax Withholding |
2021-04-13 1:05 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO |
11,088 | $37.94 | 68,971 (Direct) |
View |